Journal
← Tickers

INSP

INSP — Ruslan Averin's Analysis · 1 entries

  1. Inspire Medical Rose 16.6% on the Rarest Combination in Medtech
    ·5 min read

    Inspire Medical Rose 16.6% on the Rarest Combination in Medtech

    Ruslan Averin on Inspire Medical's Q2 2026: a 16.6% gain on results above expectations, a raised full-year outlook and a new strategic growth plan.